EUVIMEDEUVIMED entdecken
Crossref

Clinical features and outcomes of perianal disease in pediatric onset Crohn’s disease

Lin Wang, Yuhuan Wang, Ping Li, Shengnan Wang, Cuifang Zheng, Ying Huang

Digestive and Liver Disease · 2025-12 · 57 (12) · 2331-2338

DOI: 10.1016/j.dld.2025.09.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025-12. Verfasst von Lin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Children's Hospital of Fudan University, NO.399 Wanyuan Road, Minhang District, Shanghai, 201102, China. Hauptthemen laut MEDLINE: Crohn Disease, Rectal Fistula, Anus Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Rising-Star Program, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Limited data have explored perianal involvement in pediatric Crohn's disease (CD). We aimed to investigate the characteristics and clinical outcomes of pediatric onset CD with perianal disease. METHODS: The medical records of diagnosed CD with perianal disease were reviewed retrospectively. The clinical characteristics, genetic testing, treatments and surgical outcomes among very early onset (VEO group) and later onset (LO group) were investigated. The occurrence of perianal fistulizing CD (pfCD) and intestinal resection were analyzed. RESULTS: Of the 155 included patients, 52.3 % and 47.7 % were enrolled in VEO and LO group, respectively. At diagnosis, VEO patients had more colonic and rectal involvement and higher disease activity score (P < 0.001). A monogenic disease was found in 94.9 % (74/78) of patients in VEO group and in 28.6 % (2/7) of patients in LO group. Infliximab treatment was more common among LO group (P < 0.001). VEO group had a higher rate of intestinal resection (P < 0.001). During follow-up, an additional 13 VEO patients and 8 LO patients developed pfCD. Moreover, B2 behavior and recto-vaginal fistulae were found to be predictive factors for intestinal resection. CONCLUSION: VEOCD with perianal involvement is associated with higher monogenic mutation, more severe disease phenotypes, less utilization of biologics and higher rate of intestinal resection than LOCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseRectal FistulaAnus DiseasesHumansFemaleMaleRetrospective StudiesChildAdolescentInfliximabAge of OnsetSeverity of Illness IndexChild, Preschool

Stichwörter der Autor:innen

Crohn’s diseaseEarly onsetIntestinal resectionPerianal fistula

Substanzen

Infliximab

Autor:innen und Institutionen

  • Department of Gastroenterology, Children's Hospital of Fudan University, NO.399 Wanyuan Road, Minhang District, Shanghai, 201102, China.
  • Department of Gastroenterology, Children's Hospital of Fudan University, NO.399 Wanyuan Road, Minhang District, Shanghai, 201102, China. Electronic address: yhuang815@163.com.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Rising-Star Program
  • National Key Research and Development Program of China

Zitieren

APA

Wang, L., Wang, Y., Li, P., Wang, S., Zheng, C., & Huang, Y. (2025). Clinical features and outcomes of perianal disease in pediatric onset Crohn’s disease. Digestive and Liver Disease, 57(12), 2331-2338. https://doi.org/10.1016/j.dld.2025.09.003

Vancouver

Wang L, Wang Y, Li P, Wang S, Zheng C, Huang Y. Clinical features and outcomes of perianal disease in pediatric onset Crohn’s disease. Digestive and Liver Disease. 2025;57(12):2331-2338. doi:10.1016/j.dld.2025.09.003

BibTeX
@article{Wang2025,
  author = {Wang, Lin and Wang, Yuhuan and Li, Ping and Wang, Shengnan and Zheng, Cuifang and Huang, Ying},
  title = {Clinical features and outcomes of perianal disease in pediatric onset Crohn’s disease},
  journal = {Digestive and Liver Disease},
  year = {2025},
  volume = {57},
  number = {12},
  pages = {2331--2338},
  doi = {10.1016/j.dld.2025.09.003}
}
Kostenlos starten →